Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Incyte Corporation

Market Cap 19.78B 17.06B 15.69B 14.76B 27.74B 1,866B 27.98B 186B 72.37B 916B 74.22B 72.64B 3,169B P/E 2026 *
14.9x
P/E 2027 * 12.6x
Enterprise Value 14.79B 12.76B 11.73B 11.04B 20.75B 1,396B 20.93B 139B 54.14B 685B 55.53B 54.34B 2,371B EV / Sales 2026 *
2.63x
EV / Sales 2027 * 2.05x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day-0.59%
1 week-6.07%
Current month+2.33%
1 month+3.86%
3 months+5.06%
6 months+1.39%
Current year+0.22%
1 week 98.25
Extreme 98.25
109.64
1 month 92.18
Extreme 92.18
110.34
Current year 89.25
Extreme 89.25
112.29
1 year 66.74
Extreme 66.7401
112.29
3 years 50.27
Extreme 50.27
112.29
5 years 50.27
Extreme 50.27
112.29
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
06-08Free

Director

7,753 0.0039%
06-08Other

Director

0 0%
06-08Free

Director

7,753 0.0039%
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%-6.07%+43.86%+56.56% 19.78B
+0.13%+1.04%+19.47%-22.36% 61.85B
-0.59%-7.31%+61.91%+198.34% 55.69B
+2.78%+37.00%+37.00%+37.00% 41.88B
+1.21%+0.79%-55.33%-62.00% 36.15B
+0.35%+2.28%+56.98%-33.22% 29.33B
+4.56%+34.38%+141.88%-51.99% 24.52B
+1.74%+4.39%-3.12%+113.90% 16.61B
+0.16%+1.46%+57.95%+104.04% 16.2B
+0.49%-0.02%+68.18%+348.97% 13.2B
Average +1.15%+4.19%+42.88%+68.92% 31.52B
Weighted average by Cap. +1.00%+3.47%+38.09%+50.83%

Financials

2026 *2027 *
Net sales 5.63B 4.86B 4.47B 4.21B 7.9B 532B 7.97B 52.96B 20.62B 261B 21.15B 20.7B 903B 6.3B 5.44B 5B 4.7B 8.84B 595B 8.92B 59.24B 23.06B 292B 23.65B 23.15B 1,010B
Net income 1.38B 1.19B 1.09B 1.03B 1.94B 130B 1.95B 12.97B 5.05B 63.9B 5.18B 5.07B 221B 1.65B 1.42B 1.31B 1.23B 2.31B 156B 2.33B 15.5B 6.04B 76.4B 6.19B 6.06B 264B
Net Debt -4.98B -4.3B -3.95B -3.72B -6.99B -470B -7.05B -46.83B -18.23B -231B -18.7B -18.3B -798B -6.83B -5.89B -5.42B -5.1B -9.58B -645B -9.66B -64.2B -24.99B -316B -25.63B -25.09B -1,094B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
18/06/26 98.99 $ -0.76% 1,716,059
16/06/26 99.75 $ -2.19% 1,556,318
15/06/26 101.98 $ -6.04% 2,815,109
12/06/26 108.53 $ +0.65% 1,488,907
11/06/26 107.83 $ +2.32% 2,318,442
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
98.99USD
Average target price
109.35USD
Spread / Average Target
+10.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!